Testing a yeast-based treatment for C. diff infections
Part of Infections clinical trials.
This trial tests a new medicine made from a weakened yeast that is designed to fight a bacteria called C. diff, which can cause severe diarrhea. It's a first-in-human safety study, so the main goal is to see if the medicine is safe and how your body handles it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You must be generally healthy, with stable medical conditions for at least 3 months.
- You must not have had a C. diff infection before, nor been hospitalized in the last 3 years.
- You must not have taken certain antibiotics (like clindamycin or ciprofloxacin) in the last 6 months.
- You must be able to take the study capsule daily for 28 days and provide blood and stool samples.
- You must avoid probiotics and fermented foods (like yogurt, kefir, and kombucha) for a few weeks during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies using a fecal microbiota transplant (FMT)—healthy gut bacteria moved from a screened donor—to help treat recurring or hard-to-control C. difficile infection. It may help restore a healthier gut environment when standard treatments keep failing or the infection returns.
This trial tests an experimental treatment called CMTS0929 for people with a C. difficile infection that is causing diarrhea. The treatment is given through a tube placed through the nostril or mouth into the intestine, and the study will see if it is safe and helpful.
This study gives healthy volunteers a specially prepared dose of Clostridioides difficile (C. diff), a bacteria that can cause diarrhea and gut problems, to learn how the infection develops. By participating, you may help researchers better understand and prevent C. diff infections in the future.
This trial tests whether giving a stool transplant (also called FMT) can treat a new, early C. difficile infection in people who have improved while on antibiotics. It may help some people prevent the infection from coming back or worsening.
This trial compares three treatments for a severe diarrhea infection called C. diff: a fecal transplant (putting healthy donor stool into your gut), a newer antibiotic called fidaxomicin, and an older antibiotic called vancomycin. The goal is to see which works best and prevents the infection from coming back.
This study tests a freeze-dried fecal microbiota transplant (FMT) to see if it helps with diarrhea-predominant irritable bowel syndrome (IBS-D) or prevents repeat C. diff infections. FMT introduces healthy bacteria into your gut to restore balance.
Hear when a new Clostridium Difficile Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.